| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |